DEERFIELD, Ill., Dec. 8 /PRNewswire-FirstCall/ -- Baxter International Inc. today announced plans to withdraw the listing of its common stock from NYSE Arca, Inc., formerly the Pacific Exchange. Baxter's common stock will continue to be listed on the New York Stock Exchange, as well as the Chicago and Swiss Stock Exchanges.
Baxter has decided to withdraw its listing from NYSE Arca, Inc. to eliminate duplicative administrative requirements inherent with dual listings as a result of the NYSE Group's recent merger with Archipelago Holdings, the parent company of NYSE Arca. The withdrawal is expected to be effective within the next month.
Baxter does not believe that withdrawing its listing from NYSE Arca, Inc. will have any impact on the liquidity of its stock. NYSE Arca will continue to trade Baxter's stock on an unlisted trading privilege basis.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
Baxter International Inc.CONTACT: Media, Deborah Spak, +1-847-948-2349, or Investors Mary KayLadone, +1-847-948-3371, or Clare Trachtman, +1-847-948-3085, all of BaxterInternational Inc.
Web site: http://www.baxter.com/
